Literature DB >> 17205471

Improving the assessment of vancomycin-resistant enterococci by routine screening.

Susan S Huang1, Sheryl L Rifas-Shiman, Jean M Pottinger, Loreen A Herwaldt, Teresa R Zembower, Gary A Noskin, Sara E Cosgrove, Trish M Perl, Amy B Curtis, Jerome L Tokars, Daniel J Diekema, John A Jernigan, Virginia L Hinrichsen, Deborah S Yokoe, Richard Platt.   

Abstract

BACKGROUND: As infection with vancomycin-resistant enterococci (VRE) increases in hospitals, knowledge about VRE reservoirs and improved accuracy of epidemiologic measures are needed. Many assessments underestimate incidence by including prevalent carriers in at-risk populations. Routine surveillance cultures can substantially improve prevalence and incidence estimates, and assessing the range of improvement across diverse units is important.
METHODS: We performed a retrospective cohort study using accurate at-risk populations to evaluate the range of benefit of admission and weekly surveillance cultures in detecting unrecognized VRE in 14 patient-care units.
RESULTS: We assessed 165 unit-months. The admission prevalence of VRE was 2.2%-27.2%, with admission surveillance providing 2.2-17-fold increased detection. Medical units were significantly more likely to admit VRE carriers than were surgical units. Monthly incidence was 0.8%-9.7%, with weekly surveillance providing 3.3-15.4-fold increased detection. The common practice of reporting incidence using the total number of patients, rather than patients at risk, underestimated incidence by one-third. Overall, routine surveillance prevented the misclassification of 43.0% (unit range, 0%-85.7%) of "incident" carriers on the basis of clinical cultures alone and increased VRE precaution days by 2.4-fold (unit range, 2.0-2.6-fold).
CONCLUSIONS: Routine surveillance markedly increases the detection of VRE, despite variability across patient-care units. Correct denominators prevent the substantial underestimation of incidence.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17205471     DOI: 10.1086/510624

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Molecular characterization of vancomycin-resistant Enterococcus faecium isolated from intensive care units.

Authors:  Malihe Talebi; Javad Sadeghi; Mohammad R Pourshafie
Journal:  Curr Microbiol       Date:  2014-01-08       Impact factor: 2.188

2.  Intervention to reduce transmission of resistant bacteria in intensive care.

Authors:  W Charles Huskins; Charmaine M Huckabee; Naomi P O'Grady; Patrick Murray; Heather Kopetskie; Louise Zimmer; Mary Ellen Walker; Ronda L Sinkowitz-Cochran; John A Jernigan; Matthew Samore; Dennis Wallace; Donald A Goldmann
Journal:  N Engl J Med       Date:  2011-04-14       Impact factor: 91.245

Review 3.  Expanding the statistical toolbox: analytic approaches for cohort studies with healthcare-associated infectious outcomes.

Authors:  Rebecca A Pierce; Justin Lessler; Aaron M Milstone
Journal:  Curr Opin Infect Dis       Date:  2015-08       Impact factor: 4.915

4.  Impact of an environmental cleaning intervention on the presence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intensive care unit rooms.

Authors:  Eric R Goodman; Richard Platt; Richard Bass; Andrew B Onderdonk; Deborah S Yokoe; Susan S Huang
Journal:  Infect Control Hosp Epidemiol       Date:  2008-07       Impact factor: 3.254

5.  Molecular Characterization and Resistant Spectrum of Enterococci Isolated from a Haematology Unit in China.

Authors:  Jiajia Yu; Jinfang Shi; Ruike Zhao; Qingzhen Han; Xuefeng Qian; Guohao Gu; Xianfeng Zhang; Jie Xu
Journal:  J Clin Diagn Res       Date:  2015-06-01

6.  Efficacy of infection control interventions in reducing the spread of multidrug-resistant organisms in the hospital setting.

Authors:  Erika M C D'Agata; Mary Ann Horn; Shigui Ruan; Glenn F Webb; Joanna R Wares
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

Review 7.  Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic review.

Authors:  Erica S Shenoy; Molly L Paras; Farzad Noubary; Rochelle P Walensky; David C Hooper
Journal:  BMC Infect Dis       Date:  2014-03-31       Impact factor: 3.090

8.  The rise in vancomycin-resistant Enterococcus faecium in Germany: data from the German Antimicrobial Resistance Surveillance (ARS).

Authors:  Robby Markwart; Niklas Willrich; Sebastian Haller; Ines Noll; Uwe Koppe; Guido Werner; Tim Eckmanns; Annicka Reuss
Journal:  Antimicrob Resist Infect Control       Date:  2019-08-28       Impact factor: 4.887

9.  Impact of a vancomycin-resistant Enterococcus (VRE) screening result on appropriateness of antibiotic therapy.

Authors:  Jenna L Reynolds; Raelene E Trudeau; Maria Teresa Seville; Lynn Chan
Journal:  Antimicrob Steward Healthc Epidemiol       Date:  2021-11-03

10.  Mathematical modelling of vancomycin-resistant enterococci transmission during passive surveillance and active surveillance with contact isolation highlights the need to identify and address the source of acquisition.

Authors:  Agnes Loo Yee Cheah; Allen C Cheng; Denis Spelman; Roger L Nation; David C M Kong; Emma S McBryde
Journal:  BMC Infect Dis       Date:  2018-10-11       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.